BIOLASE Issued New Patent Supporting Use of Laser Technologies for Treating Eye Conditions

BIOLASE Technology, Inc. (NASDAQ: BLTI), the World's leading dental laser manufacturer and distributor, today announced that the U.S. Patent and Trademark Office has issued BIOLASE a new patent covering the use of its laser technologies for treating various conditions of the eye, including presbyopia. The patent is related to applying dyes and colored lighting to make structures in the eye more visible for various eye procedures performed with the Company's patented laser technologies. In addition, certain colorings allow for greater absorption of energy making it easier to cut at lower energy settings.

The patent is number 7,891,363 and is titled "Methods for Treating Eye Conditions." It supports previously issued patents and covers methods for treating eye disorders, such as presbyopia, the age-related loss of near vision that comes to everyone in mid-life. Presbyopia generally signifies a universal decrease in the amplitude of accommodation in the eye and currently affects over 100 million people in the U.S. and more than 2 billion people worldwide.

source: Biolase